Literature DB >> 28427291

Antioxidant therapy for management of oxidative stress induced hypertension.

Khalil Ali Ahmad1, Dai Yuan Yuan1, Waqas Nawaz2, Hong Ze1, Chen Xue Zhuo1, Bashar Talal3, Abdoh Taleb1, Enos Mais4, Ding Qilong1.   

Abstract

Hypertension is considered as the most common risk factor for cardiovascular diseases, also is regarded as a leading cause of the mortality and morbidity worldwide. The mechanisms underlying the pathological process of hypertension are not completely explained. However, there is growing evidence that increased oxidative stress plays an important role in the pathophysiology of hypertension. Several preclinical studies and clinical trials have indicated that antioxidant therapy is important for management of hypertension, using antioxidants compounds such as alpha tocopherol (Vit E) and ascorbic acid (Vit C), polyphenols with others and some antihypertensive drugs that are now in clinical use (e.g. ACEIs, ARBs, novel B-blockers, dihydropyridine CCBs) which have antioxidative pleiotropic effects. The purpose of this review is to highlight the importance of antioxidant therapy for management of oxidative stress induced hypertension. Furthermore, we review the current knowledge in the oxidative stress and its significance in hypertension.

Entities:  

Keywords:  Antioxidant therapy; endothelial dysfunction; hypertension; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28427291     DOI: 10.1080/10715762.2017.1322205

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  23 in total

Review 1.  Extracellular superoxide dismutase and its role in cancer.

Authors:  Brandon Griess; Eric Tom; Frederick Domann; Melissa Teoh-Fitzgerald
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

2.  Purification of Angiotensin-Converting Enzyme (ACE) from Sheep Kidney and Inhibition Effect of Reduced Nicotinamide Adenine Dinucleotide (NADH) on Purified ACE Activity.

Authors:  Aysenur Kiylik; Vedat Turkoglu; Zehra Bas
Journal:  Cell Biochem Biophys       Date:  2021-10-07       Impact factor: 2.194

Review 3.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

4.  Association between dietary total antioxidant capacity and hypertension in Iranian Kurdish women.

Authors:  Hawal Lateef Fateh; Narmin Mirzaei; Mohammed Ibrahim Mohialdeen Gubari; Mitra Darbandi; Farid Najafi; Yahya Pasdar
Journal:  BMC Womens Health       Date:  2022-06-25       Impact factor: 2.742

Review 5.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

Review 6.  Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.

Authors:  Santiago Cuevas; Van Anthony M Villar; Pedro A Jose
Journal:  Pharmacogenomics J       Date:  2019-02-06       Impact factor: 3.550

Review 7.  Oxidative Stress and Hypertension.

Authors:  Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

Review 8.  Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Authors:  Ramón Rodrigo; Jaime González-Montero; Camilo G Sotomayor
Journal:  Biomedicines       Date:  2021-05-30

Review 9.  The Antioxidant Therapy: New Insights in the Treatment of Hypertension.

Authors:  Daniela Sorriento; Nicola De Luca; Bruno Trimarco; Guido Iaccarino
Journal:  Front Physiol       Date:  2018-03-21       Impact factor: 4.566

10.  Optimization of a diagnostic platform for oxidation-reduction potential (ORP) measurement in human plasma.

Authors:  David Polson; Nuria Villalba; Kalev Freeman
Journal:  Redox Rep       Date:  2018-12       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.